US EditionWSA Reports 1% Organic Revenue Growth and 22% EBITDA Increase in Q2 FY 2024/25 | Hearing Health & Technology Matters
Summary by hearinghealthmatters.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
WSA Reports 1% Organic Revenue Growth and 22% EBITDA Increase in Q2 FY 2024/25 | Hearing Health & Technology Matters
LYNGE, DENMARK – WSA, a global hearing healthcare group, reported financial results for the second quarter of fiscal year 2024/25 (January 1–March 31, 2025), with organic revenue growth of 1% and a 22% increase in EBITDA. This reflects an improvement of 2.8 percentage points in the company’s EBITDA margin. “With an organic revenue growth of 1% in a volatile macro environment and a significant EBITDA margin improvement WSA, delivered satisfactory…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
